Document is current
Any future updates will be listed below
-
Authors
Mutti, Mikko
Spreen, David
Brügger, Jonas
Jordan, Fabian
Schaerli, Nicolas
Bislimaj, Albin
Subin, Behnam
Mahfoud, Felix
Sticherling, Christian
Kühne, Michael
Badertscher, Patrick
Knecht, Sven
Krisai, Philipp
-
Funding
Funding for this research was provided by:
University of Basel
- License Information
-
More Information
Article History
Received: 22 April 2026
Accepted: 6 September 2026
First Online: 16 September 2026
Declarations
Patient permission: All participants were at least 18 years old and provided written informed consent.
Disclosures: Michael Kühne reports grants from the Swiss National Science Foundation (Grant numbers 33CS30_148474, 33CS30_177520, 32473B_176178, and 32003B_197524, 33IC30_229733), the Swiss Heart Foundation, the Foundation for Cardiovascular Research Basel and the University of Basel, grants from Roche, grants from Bayer, grants from BMS, grants from Boston Scientific, grants from Daiichi Sankyo, grants from Pfizer, grants from Abbott, grants from Medtronic. Royalties from Springer Nature. Christian Sticherling: Member of Medtronic Advisory Board Europe and Boston Scientific Advisory Board Europe, received educational grants from Biosense Webster and Biotronik and a research grant from the European Union’s FP7 program and Biosense Webster and lecture and consulting fees from Abbott, Medtronic, Biosense Webster, Boston Scientific, Microport, and Biotronik, all outside the submitted work. Philipp Krisai reports speaker fees from BMS/Pfizer. Grants from the Swiss National Science Foundation, Swiss Heart Foundation, Foundation for Cardiovascular Research Basel, Machaon Foundation. Felix Mahfoud has been supported by Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche Herzstiftung. Until May 2024, FM received speaker honoraria/consulting fees from Ablative Solutions, Amgen, Astra-Zeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and Terumo all outside the submitted work. Patrick Badertscher has received research funding from the “University of Basel“, the “Stiftung für Herzschrittmacher und Elektrophysiologie”, the “Freiwillige Akademische Gesellschaft Basel”, the “Swiss Heart Foundation” and Johnson&Johnson, and reports personal fees from BMS, Boston Scientific and Abbott, all outside the submitted work. Sven Knecht has received funding of the “Swiss Heart Foundation” outside of the submitted work. The other authors have nothing to declare.
Competing interests: The authors declare no competing interests.
